Nutri Pharmaceuticals Research, Inc. Provides Company Update

LAS VEGAS--(BUSINESS WIRE)--Nutri Pharmaceuticals Research, Inc. (Pink Sheets: NRPR) recently announced First Quarter 2007 results of approximately $500,000 in revenues and $132,000 in earnings. The results reflect new marketing strategies, introduction of unique products to different markets and growing popularity of their powders for increasing manufacturing demands. These factors should continue to allow for significantly higher sales and earnings in future quarters with a large increase in its stock price.

MORE ON THIS TOPIC